Impact of Severity and Disease Course on Baricitinib Treatment Response in Adolescent Patients with Severe AA from the BRAVE-AA-PEDS Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s665, 2025. DOI: 10.25251/0fqz5v46. Disponível em: https://skin.dermsquared.com/skin/article/view/3853. Acesso em: 2 may. 2026.